DZ3000A1 - Macrolides nouveaux, procédé pour leur préparationet compositions pharmaceutiques les contenant. - Google Patents

Macrolides nouveaux, procédé pour leur préparationet compositions pharmaceutiques les contenant.

Info

Publication number: DZ3000A1
Authority: DZ; Algeria
Prior art keywords: preparation; pharmaceutical compositions; compositions containing; new macrolides; macrolides
Prior art date: 1999-01-27

Application number

DZ000002A

Other languages

English (en)

Inventor

Takushi Kaneko

William Thomas Mcmillen

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-01-27

Filing date

2000-01-05

Publication date

2004-03-27

2000-01-05 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2004-03-27 Application granted granted Critical

2004-03-27 Publication of DZ3000A1 publication Critical patent/DZ3000A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pulmonology (AREA)
Gynecology & Obstetrics (AREA)
Urology & Nephrology (AREA)
Pregnancy & Childbirth (AREA)
Ophthalmology & Optometry (AREA)
Otolaryngology (AREA)
Dermatology (AREA)
Tropical Medicine & Parasitology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Cephalosporin Compounds (AREA)

DZ000002A 1999-01-27 2000-01-05 Macrolides nouveaux, procédé pour leur préparationet compositions pharmaceutiques les contenant. DZ3000A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US11734299P	1999-01-27	1999-01-27

Publications (1)

Publication Number	Publication Date
DZ3000A1 true DZ3000A1 (fr)	2004-03-27

Family

ID=22372371

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ000002A DZ3000A1 (fr)	1999-01-27	2000-01-05	Macrolides nouveaux, procédé pour leur préparationet compositions pharmaceutiques les contenant.

Country Status (39)

Country	Link
US (1)	US6833444B2 (fr)
EP (1)	EP1147121B1 (fr)
JP (1)	JP3947360B2 (fr)
KR (1)	KR20020002380A (fr)
CN (1)	CN1342163A (fr)
AP (1)	AP2001002222A0 (fr)
AT (1)	ATE256694T1 (fr)
AU (1)	AU1675400A (fr)
BG (1)	BG105730A (fr)
BR (1)	BR9916969A (fr)
CA (1)	CA2359708C (fr)
CO (1)	CO5150229A1 (fr)
CZ (1)	CZ20012675A3 (fr)
DE (1)	DE69913738T2 (fr)
DK (1)	DK1147121T3 (fr)
DZ (1)	DZ3000A1 (fr)
EA (1)	EA200100623A1 (fr)
EE (1)	EE200100394A (fr)
ES (1)	ES2212655T3 (fr)
HK (1)	HK1042707A1 (fr)
HN (1)	HN2000000003A (fr)
HR (1)	HRP20010559A2 (fr)
HU (1)	HUP0105190A3 (fr)
ID (1)	ID30233A (fr)
IL (1)	IL144178A0 (fr)
IS (1)	IS5984A (fr)
MA (1)	MA26717A1 (fr)
NO (1)	NO20013680L (fr)
OA (1)	OA11753A (fr)
PA (1)	PA8489501A1 (fr)
PE (1)	PE20001422A1 (fr)
PT (1)	PT1147121E (fr)
SI (1)	SI1147121T1 (fr)
SK (1)	SK10172001A3 (fr)
TN (1)	TNSN00007A1 (fr)
TR (1)	TR200102128T2 (fr)
UY (1)	UY25990A1 (fr)
WO (1)	WO2000044761A2 (fr)
ZA (1)	ZA200105580B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AP1060A (en)	1998-01-02	2002-04-23	Pfizer Prod Inc	Novel erythromycin derivatives.
SI1147121T1 (en)	1999-01-27	2004-04-30	Pfizer Products Inc.	Ketolide antibiotics
US6514944B2 (en)	1999-04-16	2003-02-04	Kosan Biosciences, Inc.	Macrolide antiinfective agents
US6590083B1 (en)	1999-04-16	2003-07-08	Ortho-Mcneil Pharmaceutical, Inc.	Ketolide antibacterials
US6939861B2 (en)	1999-04-16	2005-09-06	Kosan Biosciences, Inc.	Amido macrolides
KR20020007374A (ko)	1999-04-16	2002-01-26	추후제출	매크롤라이드 항감염제
US6451768B1 (en)	1999-04-16	2002-09-17	Kosan Biosciences, Inc.	Macrolide antiinfective agents
CN1373767A (zh)	1999-04-16	2002-10-09	奥索-麦克尼尔药品公司	酮式大环内酯抗菌剂
SK15162001A3 (sk)	1999-05-24	2003-02-04	Pfizer Products Inc.	Deriváty 13-metylerytromycínu
TR200401847T4 (tr)	2000-06-30	2004-09-21	Pfizer Products Inc.	Makrolit antibiyotikler.
US20020115621A1 (en)	2000-08-07	2002-08-22	Wei-Gu Su	Macrolide antibiotics
HUP0302526A2 (hu) *	2000-12-21	2003-11-28	Glaxo Group Limited	Makrolid vegyületek, eljárás az előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
WO2003022289A1 (fr) *	2001-09-05	2003-03-20	Hokuriku Seiyaku Co., Ltd.	Medicament contenant de l'erythromycine pour traiter ou prevenir la tuberculose
ES2552682T3 (es)	2003-03-10	2015-12-01	Merck Sharp & Dohme Corp.	Agentes antibacterianos novedosos
RU2397987C2 (ru) *	2004-07-28	2010-08-27	Рэнбакси Лабораториз Лимитед	Кетолидные производные в качестве антибактериальных агентов
DE602005019786D1 (de) *	2004-12-21	2010-04-15	Pfizer Prod Inc	Makrolide
EP2077271A4 (fr) *	2006-05-01	2010-09-15	Taisho Pharmaceutical Co Ltd	Derive macrolide
AU2008316830B2 (en)	2007-10-25	2016-03-17	Cempra Pharmaceuticals, Inc.	Process for the preparation of macrolide antibacterial agents
AU2009308181B2 (en)	2008-10-24	2015-12-03	Cempra Pharmaceuticals, Inc.	Methods for treating resistant diseases using triazole containing macrolides
US9937194B1 (en)	2009-06-12	2018-04-10	Cempra Pharmaceuticals, Inc.	Compounds and methods for treating inflammatory diseases
ES2608285T3 (es)	2009-09-10	2017-04-07	Cempra Pharmaceuticals, Inc.	Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
NZ602544A (en)	2010-03-22	2014-11-28	Cempra Pharmaceuticals Inc	Crystalline forms of a macrolide, and uses therefor
SI2571506T1 (sl)	2010-05-20	2017-12-29	Cempra Pharmaceuticals, Inc.	Postopki za pripravo makrolidov in ketolidov ter njihovih intermediatov
US9815863B2 (en)	2010-09-10	2017-11-14	Cempra Pharmaceuticals, Inc.	Hydrogen bond forming fluoro ketolides for treating diseases
SG11201405895UA (en)	2012-03-27	2014-10-30	Cempra Pharmaceuticals Inc	Parenteral formulations for administering macrolide antibiotics
CN105163785A (zh)	2013-03-14	2015-12-16	森普拉制药公司	用于治疗呼吸道疾病的方法及其制剂
JP6675973B2 (ja)	2013-03-15	2020-04-08	センプラファーマシューティカルズ，インコーポレイテッド	マクロライド抗菌薬を調製するための集束的な方法
WO2014156549A1 (fr)	2013-03-28	2014-10-02	不二製油株式会社	Composition de gel de protéine d'ambérique et aliment de type fromage
CN106518939B (zh) *	2015-09-14	2019-12-31	江苏奥赛康药业有限公司	一种制备Solithromycin化合物的方法
EP3522896A4 (fr) *	2016-10-04	2020-06-17	Biopharmati SA	Cétolides à activité antibactrienne

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
YU43006B (en) *	1981-03-06	1989-02-28	Pliva Pharm & Chem Works	Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) *	1982-07-19	1984-10-02	Pfizer Inc.	N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US5141926A (en) *	1990-04-18	1992-08-25	Abbott Laboratories	Erythromycin derivatives
IL114589A (en)	1990-11-21	1999-12-22	Roussel Uclaf	Intermediates for the preparation of erythromycin derivatives
FR2697524B1 (fr)	1992-11-05	1994-12-23	Roussel Uclaf	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en)	1992-11-05	1996-06-18	Roussel Uclaf	Erythromycin derivatives
FR2719587B1 (fr) *	1994-05-03	1996-07-12	Roussel Uclaf	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2727969B1 (fr) *	1994-12-09	1997-01-17	Roussel Uclaf	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US5747466A (en) *	1995-11-08	1998-05-05	Abbott Laboratories	3-deoxy-3-descladinose derivatives of erythromycins A and B
FR2742757B1 (fr) *	1995-12-22	1998-01-30	Roussel Uclaf	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2745290B1 (fr)	1996-02-28	1998-04-03	Roussel Uclaf	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2748746B1 (fr)	1996-05-14	1998-08-14	Hoechst Marion Roussel Inc	Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine
EA001744B1 (ru)	1996-07-05	2001-08-27	Байотика Текнолоджи Лимитед (Gb)	Новые эритромицины и способы их получения
FR2751656B1 (fr)	1996-07-24	1998-10-16	Hoechst Marion Roussel Inc	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
UA51730C2 (uk)	1996-09-04	2002-12-16	Ебботт Лабораторіз	6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
FR2757168B1 (fr)	1996-12-12	1999-06-11	Hoechst Marion Roussel Inc	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2760017B1 (fr)	1997-02-27	1999-04-30	Hoechst Marion Roussel Inc	Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
AU4472897A (en)	1997-03-10	1998-09-29	Taisho Pharmaceutical Co., Ltd.	Erythromycin a derivatives
US20020025937A1 (en)	2000-03-20	2002-02-28	Yong-Jin Wu	9-oxime erythromycin derivatives
ZA987689B (en)	1997-09-02	1999-02-24	Abbott Lab	3-descladinose 6-O substituted erythromycin derivatives
ZA989835B (en)	1997-10-29	1999-05-05	Taisho Pharmaceutical Co Ltd	Erythromycin a derivatives
HN1998000159A (es)	1997-10-29	1999-02-09	Monsanto Co	Derivados de 9- amino - 3 ceto eritromicina
AU1390699A (en)	1997-11-17	1999-06-07	Imarx Pharmaceutical Corp.	A method of increasing nucleic acid synthesis with ultrasound
FR2771008B1 (fr) *	1997-11-17	2000-04-28	Hoechst Marion Roussel Inc	Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
AP1060A (en)	1998-01-02	2002-04-23	Pfizer Prod Inc	Novel erythromycin derivatives.
FR2777282B1 (fr) *	1998-04-08	2001-04-20	Hoechst Marion Roussel Inc	Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
AU5299499A (en)	1998-09-22	2000-04-10	Pfizer Products Inc.	Carbamate and carbazate ketolide antibiotics
US6100240A (en) *	1998-10-09	2000-08-08	Pfizer Inc	Macrolide derivatives
FR2785612A1 (fr) *	1998-11-10	2000-05-12	Hoechst Marion Roussel Inc	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
TR200200436T2 (tr)	1998-11-03	2002-06-21	Pfizer Inc.	Yeni makrolit antibiyotikler
FR2786188B1 (fr)	1998-11-24	2002-10-31	Hoechst Marion Roussel Inc	Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
WO2000034297A1 (fr) *	1998-12-10	2000-06-15	Pfizer Products Inc.	Antibiotiques a base de cetolides de carbamate et de carbazate
SI1147121T1 (en)	1999-01-27	2004-04-30	Pfizer Products Inc.	Ketolide antibiotics
FR2789392B1 (fr)	1999-02-04	2001-10-05	Hoechst Marion Roussel Inc	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
CN1373767A (zh)	1999-04-16	2002-10-09	奥索-麦克尼尔药品公司	酮式大环内酯抗菌剂
KR20020007374A (ko)	1999-04-16	2002-01-26	추후제출	매크롤라이드 항감염제
US6355620B1 (en)	1999-05-14	2002-03-12	Abbott Laboratories	C-2 modified erythromycin derivatives
SK15162001A3 (sk)	1999-05-24	2003-02-04	Pfizer Products Inc.	Deriváty 13-metylerytromycínu
EP1114826A3 (fr)	1999-12-29	2001-10-31	Pfizer Products Inc.	Macrolides antibactériennes et prokinétiques
EP1122261A3 (fr)	2000-01-31	2001-09-26	Pfizer Products Inc.	Macrolides antibactériennes à 13 ou 14 chainons
US20020061856A1 (en)	2000-04-24	2002-05-23	Yong-Jin Wu	Novel tricyclic erythromycin derivatives
TR200401847T4 (tr)	2000-06-30	2004-09-21	Pfizer Products Inc.	Makrolit antibiyotikler.

1999
- 1999-12-28 SI SI9930486T patent/SI1147121T1/xx unknown
- 1999-12-28 AT AT99959627T patent/ATE256694T1/de not_active IP Right Cessation
- 1999-12-28 HU HU0105190A patent/HUP0105190A3/hu unknown
- 1999-12-28 CN CN99815909A patent/CN1342163A/zh active Pending
- 1999-12-28 DE DE69913738T patent/DE69913738T2/de not_active Expired - Lifetime
- 1999-12-28 WO PCT/IB1999/002051 patent/WO2000044761A2/fr not_active Ceased
- 1999-12-28 PT PT99959627T patent/PT1147121E/pt unknown
- 1999-12-28 CA CA002359708A patent/CA2359708C/fr not_active Expired - Fee Related
- 1999-12-28 CZ CZ20012675A patent/CZ20012675A3/cs unknown
- 1999-12-28 EA EA200100623A patent/EA200100623A1/ru unknown
- 1999-12-28 IL IL14417899A patent/IL144178A0/xx unknown
- 1999-12-28 OA OA1200100191A patent/OA11753A/en unknown
- 1999-12-28 ES ES99959627T patent/ES2212655T3/es not_active Expired - Lifetime
- 1999-12-28 KR KR1020017009382A patent/KR20020002380A/ko not_active Ceased
- 1999-12-28 JP JP2000596017A patent/JP3947360B2/ja not_active Expired - Fee Related
- 1999-12-28 DK DK99959627T patent/DK1147121T3/da active
- 1999-12-28 EP EP99959627A patent/EP1147121B1/fr not_active Expired - Lifetime
- 1999-12-28 HR HR20010559A patent/HRP20010559A2/hr not_active Application Discontinuation
- 1999-12-28 BR BR9916969-0A patent/BR9916969A/pt not_active Application Discontinuation
- 1999-12-28 ID IDW00200101637A patent/ID30233A/id unknown
- 1999-12-28 AU AU16754/00A patent/AU1675400A/en not_active Abandoned
- 1999-12-28 EE EEP200100394A patent/EE200100394A/xx unknown
- 1999-12-28 SK SK1017-2001A patent/SK10172001A3/sk unknown
- 1999-12-28 HK HK02104131.0A patent/HK1042707A1/zh unknown
- 1999-12-28 AP APAP/P/2001/002222A patent/AP2001002222A0/en unknown
- 1999-12-28 TR TR2001/02128T patent/TR200102128T2/xx unknown
2000
- 2000-01-05 TN TNTNSN00007A patent/TNSN00007A1/fr unknown
- 2000-01-05 DZ DZ000002A patent/DZ3000A1/fr active
- 2000-01-06 HN HN2000000003A patent/HN2000000003A/es unknown
- 2000-01-06 PA PA20008489501A patent/PA8489501A1/es unknown
- 2000-01-06 MA MA25883A patent/MA26717A1/fr unknown
- 2000-01-06 PE PE2000000013A patent/PE20001422A1/es not_active Application Discontinuation
- 2000-01-21 CO CO00003460A patent/CO5150229A1/es unknown
- 2000-01-27 UY UY25990A patent/UY25990A1/es unknown
2001
- 2001-06-28 IS IS5984A patent/IS5984A/is unknown
- 2001-07-06 ZA ZA200105580A patent/ZA200105580B/en unknown
- 2001-07-25 BG BG105730A patent/BG105730A/xx unknown
- 2001-07-26 NO NO20013680A patent/NO20013680L/no not_active Application Discontinuation
2002
- 2002-04-05 US US10/116,969 patent/US6833444B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EE200100394A (et)	2002-10-15
EP1147121B1 (fr)	2003-12-17
IS5984A (is)	2001-06-28
CO5150229A1 (es)	2002-04-29
IL144178A0 (en)	2002-05-23
UY25990A1 (es)	2000-09-29
EP1147121A2 (fr)	2001-10-24
HUP0105190A2 (hu)	2002-04-29
PA8489501A1 (es)	2000-09-29
US6833444B2 (en)	2004-12-21
EA200100623A1 (ru)	2002-02-28
HN2000000003A (es)	2001-02-02
KR20020002380A (ko)	2002-01-09
HK1042707A1 (zh)	2002-08-23
SK10172001A3 (sk)	2002-06-04
DE69913738D1 (de)	2004-01-29
HUP0105190A3 (en)	2003-03-28
ATE256694T1 (de)	2004-01-15
AU1675400A (en)	2000-08-18
WO2000044761A3 (fr)	2001-01-04
ES2212655T3 (es)	2004-07-16
ID30233A (id)	2001-11-15
OA11753A (en)	2005-07-19
TR200102128T2 (tr)	2001-12-21
JP3947360B2 (ja)	2007-07-18
CA2359708A1 (fr)	2000-08-03
WO2000044761A2 (fr)	2000-08-03
NO20013680D0 (no)	2001-07-26
BG105730A (en)	2002-03-29
NO20013680L (no)	2001-09-19
JP2002535414A (ja)	2002-10-22
CN1342163A (zh)	2002-03-27
US20020156027A1 (en)	2002-10-24
PT1147121E (pt)	2004-04-30
PE20001422A1 (es)	2000-12-18
SI1147121T1 (en)	2004-04-30
DK1147121T3 (da)	2004-04-13
TNSN00007A1 (fr)	2005-11-10
ZA200105580B (en)	2003-02-17
HRP20010559A2 (en)	2002-08-31
MA26717A1 (fr)	2004-12-20
CZ20012675A3 (cs)	2002-04-17
BR9916969A (pt)	2001-11-06
DE69913738T2 (de)	2004-06-17
AP2001002222A0 (en)	2001-09-30
CA2359708C (fr)	2005-10-25

Publication	Publication Date	Title
DZ3000A1 (fr)	2004-03-27	Macrolides nouveaux, procédé pour leur préparationet compositions pharmaceutiques les contenant.
DZ3020A1 (fr)	2004-03-20	Acides oxamiques nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2891A1 (fr)	2003-12-15	Dérivés de tétrahydroquinoléines substués nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
FR2780057B1 (fr)	2002-09-13	Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26740A1 (fr)	2004-12-20	Derives de 13-methyl-erythromycine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ2963A1 (fr)	2004-03-15	Dérivés de bicycliques substituées nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26659A1 (fr)	2004-12-20	Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
DZ2457A1 (fr)	2004-11-08	Derivés de nicotinamide nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
MA26730A1 (fr)	2004-12-20	Composes nouveaux antagonistes de npy, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ2866A1 (fr)	2003-12-01	1-Aryl-3-arylméthyl-1,8-naphtyridine-4-(1H)-ones nouvelles, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3042A1 (fr)	2004-03-27	Dérivés d'isothiazole nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
FR2827604B1 (fr)	2003-09-19	Nouveaux derives de 1-phenylsulfonyl-1,3-dihydro-2h-indol-2- one, un procede pour leur preparation et les compositions pharmaceutiques en contenant
MA26622A1 (fr)	2004-12-20	Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ3009A1 (fr)	2004-03-27	Dérivés de quinoléine-2-one à substituant hétéroaryle nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26558A1 (fr)	2004-12-20	Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.
DZ2890A1 (fr)	2003-12-15	4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26614A1 (fr)	2004-12-20	Bicyclo [2.2.1] heptanes nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2794742B1 (fr)	2005-06-03	Nouveaux derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant
MA26465A1 (fr)	2004-12-20	Derives de quinoleine et derives de quinazoline nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26630A1 (fr)	2004-12-20	4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26707A1 (fr)	2004-12-20	Azalides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26624A1 (fr)	2004-12-20	Derives de quinazolinamines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26490A1 (fr)	2004-12-20	Derives de tetrahydroisoquinoleine nouveaux, procedes pour leur preparation et compositions pharmaceutiques les contenant.
MA26642A1 (fr)	2004-12-20	Derives de sulfonylbenzene nouveaux, procédé pour leur preparation et compositions pharmaceutiques les contenant.
MA26501A1 (fr)	2004-12-20	Derives de quinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant